Table 3 Haemoglobin changes from baseline to day of follow-up after treatment per treatment arm
| Â | Day 0-day 7 | Day 0-day 14 | Day 0-day 28 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | N | Mean 0 | Mean 7 | Mean diff, | N | Mean 0, | Mean 14, | Mean diff, | N | Mean 0, | Mean 28, | Mean diff, |
[SD] | [SD] | (P-value) | [SD] | [SD] | P-value | [SD] | [SD] | (P-value) | ||||
AL | 193 | 10.6 [1.7] | 10.2 [1.7] | −0.4 (<0.001) | 861 | 10.5 [1.9] | 10.7 [1.6] | +0.2 (0.015) | 890 | 10.7 [1.8] | 11.3 [1.6] | +0.6 (<0.001) |
AS-AQ | 403 | 10.1 [1.8] | 9.7 [1.7] | −0.4 (<0.001) | 729 | 10.0 [1.7] | 10.2 [1.5] | +0.2 (<0.001) | 667 | 10.0 [1.8] | 10.7 [1.7] | +0.7 (<0.001) |
AS-PYR | 218 | 11.4 [1.5] | 11.0 [1.5] | −0.4 (0.001) | -- | -- | -- | -- | 213 | 11.4 [1.5] | 11.9 [1.3] | +0.4 (<0.001) |
AS-SP | 272 | 10.2 [1.9] | 9.7 [1.7] | −0.5 (<0.001) | 630 | 10.0 [1.8] | 10.1 [1.6] | +0.1 (0.023) | 610 | 10.0 [1.8] | 10.7 [1.5] | +0.7 (<0.001) |
AS-SMP | -- | -- | -- | -- | -- | -- | -- | -- | 105 | 11.8 [1.8] | 12.0 [1.5] | +0.2 (0.096) |
AS-MEF | -- | -- | -- | -- | 228 | 11.4 [1.5] | 11.2 [1.3] | −0.2 0.032 | 213 | 11.5 [1.5] | 11.9 [1.1] | +0.3 (0.0003) |
AS | 348 | 10.2 [1.7] | 9.5 [1.5] | −0.7 (<0.001) | 348 | 10.2 [1.7] | 10.3 [1.4] | +0.1 (0.198) | 297 | 10.2 [1.8] | 11.0 [1.5] | +0.8 (<0.001) |
SP-AQ | -- | -- | -- | -- | 133 | 10.0 [1.6] | 10.4 [1.5] | +0.4 (0.001) | 131 | 10.0 [1.6] | 11.1 [1.5] | +1.1 (<0.001) |
SP | 114 | 10.0 [1.8] | 9.4 [1.5] | −0.6 (<0.001) | 679 | 10.2 [1.8] | 10.3 [1.7] | +0.1 (0.102) | 706 | 10.3 [1.8] | 10.9 [1.7] | +0.6 (<0.001) |
AQ | 104 | 9.9 [1.5] | 9.7 [1.5] | −0.2 (0.3) | 62 | 9.7 [1.6] | 9.9 [1.3] | +0.2 (0.251) | 97 | 9.9 [1.5] | 10.4 [1.6] | +0.5 (0.002) |
CQ | 1016 | 10.9 [1.9] | 10.6 [1.7] | −0.3 (<0.001) | 978 | 10.9 [1.9] | 11.0 [1.7] | +0.1 (0.065) | 162 | 9.86 [1.63] | 10.01 [1.54] | +0.2 (0.261) |